Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration

NCT06223074 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis Relapsing Remitting
Treatment

Interventions

OTHER: IV Methylprednisolone administration
DRUG: Nasal Methylprednisolone (MT)

Sponsor

Universidad Nacional Autonoma de Mexico

Collaborators

[object Object]